Thrombosis News and Research

Latest Thrombosis News and Research

Achievable outcomes focus of long-term postmenopausal weight loss

Research shows that successful long-term weight loss in postmenopausal women is associated with implementation of realistic and achievable dietary changes such as reducing consumption of sugar-sweetened drinks and desserts.

30 Aug 2012

Oral lesion progression markers validated, discovered

Loss of heterozygosity can reliably differentiate between individuals with premalignant oral lesions who are likely to progress to oral carcinoma, and those who are not, show study results.

30 Aug 2012

Sterotactic radiotherapy offers good results in recurrent head and neck cancer

For patients with recurring head and neck cancer, stereotactic body radiotherapy offers a feasible and tolerable salvage treatment, with median overall survival rates of more than 1 year, report researchers.

30 Aug 2012

Non-right-handedness increased in BD patients

Patients with bipolar disorder are around twice as likely to be non-right-handed as mentally healthy individuals, study results show.

30 Aug 2012

Closing in on neurologic biomarker diagnosis

A panel of five cerebrospinal fluid biomarkers may help doctors to accurately diagnose patients with various forms of dementia and parkinsonian disorders, research published in the Archives of Neurology suggests.

30 Aug 2012

Anastomotic leakage does not increase rectal cancer recurrence risk

Incidence of clinical anastomotic leak after anterior resection for patients with rectal adenocarcinoma does not increase the risk for local disease recurrence, despite previous studies indicating the opposite, report US researchers.

30 Aug 2012

Pressure’s not off for diabetic feet

Custom-made footwear for diabetes patients must offload pressure if it is to be effective at preventing ulceration, Dutch researchers emphasize.

30 Aug 2012

Duration of untreated bipolar disorder ‘too long’

The mean duration of untreated bipolar disorder is “unacceptably” long, say French researchers who report that an increased duration is associated with more mood episodes, more suicidal behavior, and greater mood instability.

30 Aug 2012

Combination of POZEN’s PA32540 and clopidogrel results in greater antiplatelet effects

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced the presentation of Phase 1 data, at the European Society of Cardiologists 2012 Congress, from a study of PA32540, a novel coordinated-delivery tablet of enteric-coated (EC) aspirin (325 mg) and immediate-release (IR) omeprazole (40 mg).

30 Aug 2012

PROTECT: Still no clear winner in the battle of the stent generations

Three-year rates of stent thrombosis with zotarolimus- and sirolimus-eluting stents are low and comparable, show results of the PROTECT trial.

29 Aug 2012

Childhood coagulation marker levels distinct from adulthood

Levels of key coagulation markers significantly vary with age in children, research reveals, potentially affecting the diagnosis and treatment of pediatric thrombotic and hemorrhagic disease.

29 Aug 2012

Endoscopic microsurgery effective for giant rectal adenomas

Transanal endoscopic microsurgery on large rectal adenomas provides results comparable to or better than those reported for alternative techniques, shows a UK study.

29 Aug 2012

Elevated CRP is phenotype for familial preserved cognition

The first-degree relatives of very old people with preserved cognition and elevated C-reactive protein have a low risk for developing dementia, research shows.

29 Aug 2012

Where there’s no smoke, there’s less bladder cancer

Giving up smoking can significantly improve clinical outcomes in patients with urothelial carcinoma of the bladder, report US researchers.

29 Aug 2012

Vitamin to the rescue in fight with ‘superbugs’

High doses of vitamin B3 may help fight against so called “superbugs” such as methicillin-resistant Staphylococcus aureus, show study results.

29 Aug 2012

Physicians’ emotional, institutional barriers prolong medical futility at end of life

The most common reasons that clinicians give to explain medically futile treatment at the end of life are emotional difficulties, such as a fear of talking about death, and institutional barriers, such as hospital departments expecting them to “do everything possible,” report German researchers.

29 Aug 2012

Omitting aspirin leads to less bleedings but does not increase risk of stent thrombosis, MI

Lifelong anticoagulation is necessary for the prevention of stroke in patients with rhythm disturbances and with mechanical valves. Patients who have a coronary stent implanted also need the antiplatelet drugs aspirin and clopidogrel to prevent the rare but lethal complication of stent thrombosis.

29 Aug 2012

Elixir Medical’s DESyne BD Novolimus Eluting Coronary Stent System receives CE Mark approval

Elixir Medical Corporation, a developer of product platforms that combine state-of-the-art medical devices with advanced pharmaceuticals, announced that it has received CE Mark approval for its DESyne BD Novolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

29 Aug 2012

Global platelet reactivity effectively identifies ACS patients at high risk of ischemic events

Global platelet reactivity is more effective than responsiveness to clopidogrel in identifying acute coronary syndrome (ACS) patients at high risk of ischemic events, according to research presented at the ESC Congress today. The results from the RECLOSE 2-ACS study were presented by Dr Rossella Marcucci from Italy.

28 Aug 2012

Personalized antiplatelet treatment leads to better outcomes in patients undergoing PCI

Personalized antiplatelet treatment leads to better outcomes than standard antiplatelet treatment in patients undergoing coronary stent implantation, according to results from the MADONNA study presented at ESC Congress 2012.

28 Aug 2012